Results of the two incidence screenings in the National Lung Screening Trial. - Wikidata - awgldk - TriplyDB

Results of the two incidence screenings in the National Lung Screening Trial.

Results of the two incidence screenings in the National Lung Screening Trial.

http://www.wikidata.org/entity/Q34978058

about

Role of chest computed tomography in prevention of occupational respiratory disease: review of recent literature Risk factors assessment and risk prediction models in lung cancer screening candidates Implementing lung cancer screening in the real world: opportunity, challenges and solutions Screening for lung cancer using low-dose computed tomography: concerns about the application in low-risk individuals Components necessary for high-quality lung cancer screening: American College of Chest Physicians and American Thoracic Society Policy Statement Management strategy of solitary pulmonary nodules Lung cancer screening with low-dose computed tomography for primary care providers Cost-Effectiveness Analyses of Lung Cancer Screening Strategies Using Low-Dose Computed Tomography: a Systematic Review.Blizzard Sign as a specific endobronchial ultrasound image for ground glass opacity: A case report.Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada Data-driven decision support for radiologists: re-using the National Lung Screening Trial dataset for pulmonary nodule management.Small cell lung cancer: where do we go from here?A Bayesian model for estimating multi-state disease progression Validation of a blood protein signature for non-small cell lung cancer Prevalence and variables associated with solitary pulmonary nodules in a routine clinic-based population: a cross-sectional study.Lung cancer screening: subsequent evidences of national lung screening trial.Projected outcomes using different nodule sizes to define a positive CT lung cancer screening examination.Increased expression of the Th17-IL-6R/pSTAT3/BATF/RorγT-axis in the tumoural region of adenocarcinoma as compared to squamous cell carcinoma of the lung.CHoMP: a chemoenzymatic histology method using clickable probes.The Hundred Person Wellness Project and Google's Baseline Study: medical revolution or unnecessary and potentially harmful over-testing?Very low-dose (0.15 mGy) chest CT protocols using the COPDGene 2 test object and a third-generation dual-source CT scanner with corresponding third-generation iterative reconstruction software.Nanocytological field carcinogenesis detection to mitigate overdiagnosis of prostate cancer: a proof of concept study Incidentally diagnosed pulmonary nodule: a diagnostic algorithm.Lung cancer detectability by test, histology, stage, and gender: estimates from the NLST and the PLCO trials Significance of plasma hepatocyte growth factor in diagnosis of benign and malignant solitary pulmonary nodules.Is generalization of exhaled CO assessment in primary care helpful for early diagnosis of COPD?Two-year survival of patients screened for transcatheter aortic valve replacement with potentially malignant incidental findings in initial body computed tomography ESR/ERS white paper on lung cancer screening Clinical and radiographic differentiation of lung nodules caused by mycobacteria and lung cancer: a case-control study.Blinded Validation of Breath Biomarkers of Lung Cancer, a Potential Ancillary to Chest CT Screening.18F-FDG PET/CT assessment of histopathologically confirmed mediastinal lymph nodes in non-small cell lung cancer using a penalised likelihood reconstruction Diagnostic Value of Serum miR-182, miR-183, miR-210, and miR-126 Levels in Patients with Early-Stage Non-Small Cell Lung Cancer.Organ Dose and Attributable Cancer Risk in Lung Cancer Screening with Low-Dose Computed Tomography.The Fate of Patients with Solitary Pulmonary Nodules: Clinical Management and Radiation Exposure Associated Differences in Patient Outcomes of Prevalence, Interval, and Screen-Detected Lung Cancers in the CT Arm of the National Lung Screening Trial.Significance of pulmonary nodules in multi-detector computed tomography scan of noncancerous patients.Lung cancer screening using low dose CT: screening population and positive results definition.Diagnostic accuracy of contrast-enhanced computed tomography and positron emission tomography with 18-FDG in identifying malignant solitary pulmonary nodules [Systematic Review of the Methodology Quality in Lung Cancer Screening Guidelines].Predicting the Mortality Benefit of CT Screening for Second Lung Cancer in a High-Risk Population.

P2860

Q23911871-E22D050D-B656-4968-907B-BA84E949C33E Q26747819-A8B691D1-E52A-46AE-93EF-7C39BF7BFCE9 Q26784107-1A73E6AA-4F45-4934-9173-9C0E90624372 Q26799888-4040AF05-2C20-4295-AD31-749E5673C932 Q27021984-D442CB18-F64C-49FC-A1D5-E7BE5235D5D7 Q27022971-133489FF-BF48-4B62-9C1A-54F1C545EB83 Q28390878-EE507BAA-9031-470D-82D0-EBCB7ECF9895 Q30251912-66D67E89-BA91-44AB-A59F-55D0AA5769B1 Q30428509-30BEE47F-2168-4BE8-AC0A-298A1ED024EE Q30587070-A7E7E6A8-754C-4D43-8022-078025F745A2 Q30833381-C752FFDA-3CAD-46E1-8D92-935FB1B352A8 Q33872327-42A05476-8018-4449-B7DF-8B0C9A408927 Q33900778-4D59DDB6-183A-4E84-A42C-68881892518D Q34008245-F62FD8E6-B3D4-4966-B9B4-D2EA78F9E972 Q34021407-4340B861-071B-4C0D-B67E-73BEB901CC94 Q34195009-6B79AE7A-9B19-4468-AAB6-EA911DD6364E Q34396038-B865E1DF-FDED-42D1-B019-C66A2A9A2478 Q34665081-11074F3A-0E09-4F49-BE93-844C6ECAB05D Q34785017-21BE4C7C-96EC-46BF-9771-E8C59001A913 Q34887066-303A013B-7C7A-424C-9236-482D19A42BD4 Q34956435-28AA35D3-589A-47C2-A138-9E39C90112A6 Q35112929-DECD8543-BD32-459F-9169-22F81940B393 Q35145639-ED93DA9C-322A-4958-BBB4-4F9756A25F51 Q35171942-E8A9A937-02A7-4E58-A403-58E2AD437677 Q35406935-85BD4DFC-7C52-4108-A92E-438195ECDAA8 Q35616872-ADDC5EB6-5609-4EDD-869D-41923864507D Q35718230-AE22A034-0E4C-4CA0-BAB4-1A5E969A37EE Q35801394-54116A3E-59EF-42BF-BD63-3790DA956C21 Q35826719-70EE774D-7CA7-46BF-9F5B-480E4F27284D Q35876638-B689C83F-CDBA-4C4E-9445-757AE6FE25D7 Q35935680-BA216300-DC96-4D2F-AC3E-BE826672E251 Q35993714-7E9EB664-E6CE-4B0D-B2FB-EF338FCC39F2 Q36024063-4D6EE18F-3ACE-4FC0-8C15-D37D59C55884 Q36071723-4FAF2A04-CFD7-45D9-856B-4682BFEBC91A Q36100327-5C433CF0-4126-4279-9FA0-FA7AD8B3E5E6 Q36110660-D676B380-7B1C-4C05-8CDE-692A3ABB0140 Q36138370-BB9727A4-D0F9-4045-BC8C-5364AC608CA1 Q36151227-4947C384-628F-4D20-AE5D-976B11D54F3B Q36168320-E0D5A8FB-5B11-4F6B-AECF-6C45D58E710D Q36180316-0B479739-AD9F-4FC3-809D-AD9C4B5C3E27

P2860

Results of the two incidence screenings in the National Lung Screening Trial.

http://www.wikidata.org/entity/Q34978058

description

2013 nî lūn-bûn

@nan

2013 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Results of the two incidence screenings in the National Lung Screening Trial.

@ast

Results of the two incidence screenings in the National Lung Screening Trial.

@en

Results of the two incidence screenings in the National Lung Screening Trial.

@nl

type

label

Results of the two incidence screenings in the National Lung Screening Trial.

@ast

Results of the two incidence screenings in the National Lung Screening Trial.

@en

Results of the two incidence screenings in the National Lung Screening Trial.

@nl

prefLabel

Results of the two incidence screenings in the National Lung Screening Trial.

@ast

Results of the two incidence screenings in the National Lung Screening Trial.

@en

Results of the two incidence screenings in the National Lung Screening Trial.

@nl

P1433

Q34978058-0044FEFC-72BC-4252-9C53-658075D45478

P1476

Q34978058-AFE8EA45-EC41-44A1-AABB-5A178C8D049B

P2093

Q34978058-18DE593C-7538-4BAE-A628-06CF016CFA9F

Q34978058-22E0DE1C-4479-47B4-B6EA-0E23A16B2592

Q34978058-2432862B-35D4-4438-8ADF-307CB48D081B

Q34978058-2C5958BB-6E07-4D7A-8D99-64E9AF01B677

Q34978058-2ED806C0-57B5-4A31-973A-F6F635A628C6

Q34978058-35BD2D7A-5B91-49FC-A0FF-30B024D1C582

Q34978058-3D73216D-2496-429F-BE3A-9D4930A23254

Q34978058-3FB3D280-F013-489B-8898-2A5901F6F4AA

Q34978058-5679CEAA-7243-4C75-9C31-732ED0859126

Q34978058-57CF9E24-D49C-44F7-A2C2-61E872522DF4

P2860

Q34978058-0927ED84-8F02-47D7-BFD2-42602D64364C

Q34978058-173AFAE8-5A39-46F6-B4C3-6EC4536A9ECB

Q34978058-43295AFB-5292-4B43-9DC4-9529132EF471

Q34978058-43A2E042-EC74-47B7-9133-F711B071B27B

Q34978058-47165522-1F88-4746-B4D9-C87C41AD0AC6

Q34978058-482EEDEA-6089-4D3B-B9C8-4E97381BB175

Q34978058-4D8BD89B-01E3-483A-9FB0-887C461532BB

Q34978058-6228A9F5-7970-499C-B5AA-56246CF11ECF

Q34978058-6702BD45-6D68-4E81-BF45-6BF8B6229A82

Q34978058-68512663-AB30-4015-AEE8-5F80969D3D48

P304

Q34978058-BA7DEE5A-922D-4304-821B-123C77B5E70B

P31

Q34978058-693CB6BB-88B8-4CB0-9D95-18B4C9B85EDD

P356

Q34978058-30E5AD4A-2D9C-4603-A48F-09616FDBBC0A

P407

Q34978058-CB48750D-10E4-4D22-922D-14D37AB0564F

P433

Q34978058-983FDF86-7A26-44B5-A6C8-1E622C20473A

P478

Q34978058-A19B0713-4B54-4680-B47E-EF164590CA35

P50

Q34978058-4ED5484A-3B94-4C64-9876-49151B0F3022

Q34978058-C754642F-03EA-4560-90CE-E9FCCE763E75

Q34978058-F43631FC-631B-42A6-BF9F-7C12A2916C48

P577

Q34978058-65B4085E-3B74-4E20-9FE9-AC54F359197E

P698

Q34978058-42D5E0C0-969B-4B0E-9BD6-FA1C33196911

P932

Q34978058-80C07961-F853-4E04-96C0-1912BECD5FA4

P356

P1433

The New England Journal of Medicine

P1476

Results of the two incidence screenings in the National Lung Screening Trial.

@en

P2093

Amanda Jain

http://www.w3.org/2001/XMLSchema#string

Brenda Brewer

http://www.w3.org/2001/XMLSchema#string

Christine D Berg

http://www.w3.org/2001/XMLSchema#string

Constantine A Gatsonis

http://www.w3.org/2001/XMLSchema#string

David S Gierada

http://www.w3.org/2001/XMLSchema#string

Fenghai Duan

http://www.w3.org/2001/XMLSchema#string

Gordon C Jones

http://www.w3.org/2001/XMLSchema#string

Irene Mahon

http://www.w3.org/2001/XMLSchema#string

JoRean Sicks

http://www.w3.org/2001/XMLSchema#string

Joshua M Rathmell

http://www.w3.org/2001/XMLSchema#string

P2860

Reduced lung-cancer mortality with low-dose computed tomographic screening

International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma

The National Lung Screening Trial: overview and study design.

Baseline characteristics of participants in the randomized national lung screening trial

The National Lung Screening Trial's Endpoint Verification Process: determining the cause of death.

Description and implementation of a quality control program in an imaging-based clinical trial.

Genetic evidence linking lung cancer and COPD: a new perspective

Lung cancer epigenetics and genetics.

Results of initial low-dose computed tomographic screening for lung cancer

Selection criteria for lung-cancer screening.

P304

920-931

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1056/NEJMOA1208962

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

369

http://www.w3.org/2001/XMLSchema#string

P50

Timothy R. Church

Denise R. Aberle

P577

2013-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24004119

http://www.w3.org/2001/XMLSchema#string

P932

4307922

http://www.w3.org/2001/XMLSchema#string